Targeting Host Innate and Adaptive Immunity to Achieve the Functional Cure of Chronic Hepatitis B.

ABSTRACT: Despite the availability of an effective preventive vaccine for hepatitis B virus (HBV) for over 38 years, chronic HBV (CHB) infection remains a global health burden with around 257 million patients. The ideal treatment goal for CHB infection would be to achieve complete cure; however, current therapies such as peg-interferon and nucleos(t)ide analogs are unable to achieve the functional cure, the newly set target for HBV chronic infection. Considering the fact functional cure has been accepted as an endpoint in the treatment of chronic hepatitis B by scientific committee, the development of alternative therapeutic strategies is urgently needed to functionally cure CHB infection. A promising target for future therapeutic strategies is immune modulation to restore dysfunctional HBV-specific

SUBMITTER: Ezzikouri S 

PROVIDER: S-EPMC7349973 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature